-Scroll.in It is important to learn from the Covid-19 crisis and transform policies and systems. Or we are destined to repeat our mistakes? Humans tend to limit memories of horrors faced in the past as a coping mechanism. In our hurry to return to normalcy, as the world and India learns to live with Covid-19, we should not forget the lessons this crisis taught us. The most important of these is the...
More »SEARCH RESULT
Total Matching Records found : 2894
Nasal vaccine priced at Rs 800 before taxes -GS Mudur
-The Telegraph Centre’s vaccine policy advisers earlier this week approved release of intranasal vaccine into the private market New Delhi: Indian vaccine maker Bharat Biotech announced on Tuesday that its intranasal Covid-19 vaccine, approved by the Centre as a booster dose, would be available at private Hospitals for Rs 800 plus additional taxes and service charges per dose. People 18 years or older who have taken two doses of Covaxin, Covishield or any...
More »Prof. Satyajit Rath, National Institute of Immunology, interviewed by Sandipan Talukdar (Newsclick.in)
-Newsclick.in There is no evidence either of the subvariant being particularly more transmissible than other variants of the Omicron lineage, according to the eminent immunologist. BF.7, the new Omicron subvariant which has triggered a surge in China, has also been detected in India. Till the filing of this article, India hadrecorded only four BF.7 cases. New precautionary measures taken by the government, including advisories on wearing masks in public places and avoiding...
More »BF.7 and XBB: ‘India doing fine, masks hold little value if…’ says Dr Gagandeep Kang -Poulomi Ghosh
-Hindustan Times Virologist Dr Gagandeep Kang said India does not need restrictions but precautions but China will see a lot of infections like that of India's second wave. Virologist Dr Gagandeep Kang on Friday broke down the current Covid situation in India in comparison with China and said India is doing fine and won't require travel restrictions but China will see 'lots and lots of infections', similar to what India witnessed during...
More »The need to make cancer drugs affordable -Biswajit Dhar and Chetali Rao
-The Hindu With the Rajya Sabha Standing Committee on Health expressing concern over the high cost of cancer treatment, the Government invoking Section 100 of the Patents Act is a way forward The subject of the spiralling costs of cancer medicines and their implications that have frequently been highlighted the world over were dwelled on in a recent report (“Cancer Care Plan and Management”) by the Rajya Sabha’s Standing Committee on Health....
More »
